MENLO PARK, Calif.— Biotechnology and genetic science company Avellino Labs has added four internationally renowned ophthalmologists—Eric Donnenfeld, MD, Edward Holland, MD, Richard Lindstrom, MD and Elizabeth Yeu, MD—to its board of medical advisors. “We have long benefitted from the expert input of the world-class clinicians, many of whom have been a part of the medical advisory team since Avellino Labs launched in 2008,” said Gene Lee, chairman of the board for Avellino Labs. “We are profoundly honored to welcome these respected ophthalmic surgeons to our medical advisory board and look forward to their insights supporting our strategic market expansion.”

The four U.S.-based doctors have been instrumental in the development of the most widely implemented diagnostics and therapeutic treatments for the cornea, including refractive surgery. Collectively, their demonstrated abilities to develop science and share it in a meaningful way with the anterior segment community are the driving factors behind their appointments to the Avellino Labs medical advisory board, the company said.